CHAMPIONS ONCOLOGY, INC. Increase (Decrease) in Accounts Receivable
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Increase (Decrease) in Accounts Receivable of $414.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-09-11
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts receivable for the quarter ending 2026-07-31 was $414.00K.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts receivable for the quarter ending 2026-04-30 was $1.19M.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts receivable for the quarter ending 2026-01-31 was $498.00K, a 90.55% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts receivable for the quarter ending 2025-10-31 was $2.08M, a 69.08% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts receivable for fiscal 2026 was $2.00M, a 39.42% increase from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts receivable for fiscal 2025 was $1.44M, a 27.88% decline from fiscal 2024.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts receivable for fiscal 2024 was $1.99M.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$1.31M, a 146.42% decline from fiscal 2022.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-07-31 | $414.00K 10-Q · filed 2026-09-11 | $1.60M derived: sum of 2 quarters · filed 2026-09-11 | $2.10M derived: sum of 3 quarters · filed 2026-09-11 | $4.17M derived: sum of 4 quarters · filed 2026-09-11 |
| 2026-04-30 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | $1.68M derived: sum of 2 quarters · filed 2026-07-27 | $3.76M derived: sum of 3 quarters · filed 2026-07-27 | $2.00M 10-K · filed 2026-07-27 |
| 2026-01-31 | $498.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-12 | $2.58M derived: sum of 2 quarters · filed 2026-03-12 | $817.00K 10-Q · filed 2026-03-12 | -$3.68M derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-10-31 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15 | $319.00K 10-Q · filed 2025-12-15 | -$4.18M derived: sum of 3 quarters · filed 2026-09-11 | $1.09M derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-07-31 | -$1.76M 10-Q · filed 2026-09-11 | -$6.26M derived: sum of 2 quarters · filed 2026-09-11 | -$987.00K derived: sum of 3 quarters · filed 2026-09-11 | $242.00K derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-04-30 | -$4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | $772.00K derived: sum of 2 quarters · filed 2026-07-27 | $2.00M derived: sum of 3 quarters · filed 2026-07-27 | $1.44M 10-K · filed 2026-07-27 |
| 2025-01-31 | $5.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-12 | $6.50M derived: sum of 2 quarters · filed 2026-03-12 | $5.94M 10-Q · filed 2026-03-12 | $7.73M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-10-31 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15 | $664.00K 10-Q · filed 2025-12-15 | $2.46M derived: sum of 3 quarters · filed 2025-12-15 | $2.71M derived: sum of 4 quarters · filed 2025-12-15 |
| 2024-07-31 | -$565.00K 10-Q · filed 2025-09-15 | $1.23M derived: sum of 2 quarters · filed 2025-09-15 | $1.48M derived: sum of 3 quarters · filed 2025-09-15 | $327.00K derived: sum of 4 quarters · filed 2025-09-15 |
| 2024-04-30 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23 | $2.04M derived: sum of 2 quarters · filed 2025-07-23 | $892.00K derived: sum of 3 quarters · filed 2025-07-23 | $1.99M 10-K · filed 2025-07-23 |
| 2024-01-31 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | -$902.00K derived: sum of 2 quarters · filed 2025-03-17 | $197.00K 10-Q · filed 2025-03-17 | $266.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-10-31 | -$1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-16 | -$53.00K 10-Q · filed 2024-12-16 | $16.00K derived: sum of 3 quarters · filed 2024-12-16 | -$927.00K derived: sum of 4 quarters · filed 2024-12-16 |
| 2023-07-31 | $1.10M 10-Q · filed 2024-09-13 | $1.17M derived: sum of 2 quarters · filed 2024-09-13 | $225.00K derived: sum of 3 quarters · filed 2024-09-13 | -$51.00K derived: sum of 4 quarters · filed 2024-09-13 |
| 2023-04-30 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-19 | -$874.00K derived: sum of 2 quarters · filed 2024-07-19 | -$1.15M derived: sum of 3 quarters · filed 2024-07-19 | -$1.31M 10-K · filed 2024-07-19 |
| 2023-01-31 | -$943.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-15 | -$1.22M derived: sum of 2 quarters · filed 2024-03-15 | -$1.38M 10-Q · filed 2024-03-15 | -$252.00K derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-10-31 | -$276.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-13 | -$434.00K 10-Q · filed 2023-12-13 | $691.00K derived: sum of 3 quarters · filed 2023-12-13 | $1.06M derived: sum of 4 quarters · filed 2023-12-13 |
| 2022-07-31 | -$158.00K 10-Q · filed 2023-09-13 | $967.00K derived: sum of 2 quarters · filed 2023-09-13 | $1.34M derived: sum of 3 quarters · filed 2023-09-13 | $1.83M derived: sum of 4 quarters · filed 2023-09-13 |
| 2022-04-30 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-24 | $1.50M derived: sum of 2 quarters · filed 2023-07-24 | $1.99M derived: sum of 3 quarters · filed 2023-07-24 | $2.82M 10-K · filed 2023-07-24 |
| 2022-01-31 | $372.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16 | $868.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.69M 10-Q · filed 2023-03-16 | $2.56M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-10-31 | $496.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-13 | $1.32M 10-Q · filed 2022-12-13 | $2.19M derived: sum of 3 quarters · filed 2022-12-13 | $2.35M derived: sum of 4 quarters · filed 2022-12-13 |
| 2021-07-31 | $825.00K 10-Q · filed 2022-09-12 | $1.69M derived: sum of 2 quarters · filed 2022-09-12 | $1.85M derived: sum of 3 quarters · filed 2022-09-12 | $2.83M derived: sum of 4 quarters · filed 2022-09-12 |
| 2021-04-30 | $864.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | $1.03M derived: sum of 2 quarters · filed 2022-07-22 | $2.00M derived: sum of 3 quarters · filed 2022-07-22 | $2.27M 10-K · filed 2022-07-22 |
| 2021-01-31 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-15 | $1.14M derived: sum of 2 quarters · filed 2022-03-15 | $1.40M 10-Q · filed 2022-03-15 | $1.74M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-10-31 | $974.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-13 | $1.24M 10-Q · filed 2021-12-13 | $1.57M derived: sum of 3 quarters · filed 2021-12-13 | $2.33M derived: sum of 4 quarters · filed 2021-12-13 |
| 2020-07-31 | $263.00K 10-Q · filed 2021-09-13 | $599.00K derived: sum of 2 quarters · filed 2021-09-13 | $1.36M derived: sum of 3 quarters · filed 2021-09-13 | $1.41M derived: sum of 4 quarters · filed 2021-09-13 |
| 2020-04-30 | $336.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26 | $1.09M derived: sum of 2 quarters · filed 2021-07-26 | $1.15M derived: sum of 3 quarters · filed 2021-07-26 | $670.00K 10-K · filed 2021-07-26 |
| 2020-01-31 | $759.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-15 | $814.00K derived: sum of 2 quarters · filed 2021-03-15 | $334.00K 10-Q · filed 2021-03-15 | $810.00K derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-10-31 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-14 | -$425.00K 10-Q · filed 2020-12-14 | $51.00K derived: sum of 3 quarters · filed 2020-12-14 | -$680.00K derived: sum of 4 quarters · filed 2020-12-14 |
| 2019-07-31 | -$480.00K 10-Q · filed 2020-09-14 | -$4.00K derived: sum of 2 quarters · filed 2020-09-14 | -$735.00K derived: sum of 3 quarters · filed 2020-09-14 | $199.00K derived: sum of 4 quarters · filed 2020-09-14 |
| 2019-04-30 | $476.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28 | -$255.00K derived: sum of 2 quarters · filed 2020-07-28 | $679.00K derived: sum of 3 quarters · filed 2020-07-28 | $531.00K 10-K · filed 2020-07-28 |
| 2019-01-31 | -$731.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-16 | $203.00K derived: sum of 2 quarters · filed 2020-03-16 | $55.00K 10-Q · filed 2020-03-16 | $986.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-10-31 | $934.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-16 | $786.00K 10-Q · filed 2019-12-16 | $1.72M derived: sum of 3 quarters · filed 2019-12-16 | $2.12M derived: sum of 4 quarters · filed 2019-12-16 |
| 2018-07-31 | -$148.00K 10-Q · filed 2019-09-16 | $783.00K derived: sum of 2 quarters · filed 2019-09-16 | $1.19M derived: sum of 3 quarters · filed 2019-09-16 | $1.04M derived: sum of 4 quarters · filed 2019-09-16 |
| 2018-04-30 | $931.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29 | $1.34M derived: sum of 2 quarters · filed 2019-07-29 | $1.19M derived: sum of 3 quarters · filed 2019-07-29 | $1.60M 10-K · filed 2019-07-29 |
| 2018-01-31 | $406.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18 | $262.00K derived: sum of 2 quarters · filed 2019-03-18 | $669.00K 10-Q · filed 2019-03-18 | $941.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-10-31 | -$144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-17 | $263.00K 10-Q · filed 2018-12-17 | $535.00K derived: sum of 3 quarters · filed 2018-12-17 | $672.00K derived: sum of 4 quarters · filed 2018-12-17 |
| 2017-07-31 | $407.00K 10-Q · filed 2018-09-14 | $679.00K derived: sum of 2 quarters · filed 2018-09-14 | $816.00K derived: sum of 3 quarters · filed 2018-09-14 | $1.08M derived: sum of 4 quarters · filed 2018-09-14 |
| 2017-04-30 | $272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | $409.00K derived: sum of 2 quarters · filed 2018-07-30 | $672.00K derived: sum of 3 quarters · filed 2018-07-30 | $986.00K 10-K · filed 2018-07-30 |
| 2017-01-31 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | $400.00K derived: sum of 2 quarters · filed 2018-03-19 | $714.00K 10-Q · filed 2018-03-19 | -$82.00K derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-10-31 | $263.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | $577.00K 10-Q · filed 2017-12-15 | -$219.00K derived: sum of 3 quarters · filed 2017-12-15 | -$6.00K derived: sum of 4 quarters · filed 2017-12-15 |
| 2016-07-31 | $314.00K 10-Q · filed 2017-09-14 | -$482.00K derived: sum of 2 quarters · filed 2017-09-14 | -$269.00K derived: sum of 3 quarters · filed 2017-09-14 | $198.00K derived: sum of 4 quarters · filed 2017-09-14 |
| 2016-04-30 | -$796.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | -$583.00K derived: sum of 2 quarters · filed 2017-07-28 | -$116.00K derived: sum of 3 quarters · filed 2017-07-28 | $282.00K 10-K · filed 2017-07-28 |
| 2016-01-31 | $213.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17 | $680.00K derived: sum of 2 quarters · filed 2017-03-17 | $1.08M 10-Q · filed 2017-03-17 | $1.05M derived: sum of 4 quarters · filed 2017-03-17 |
| 2015-10-31 | $467.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14 | $865.00K 10-Q · filed 2016-12-14 | $833.00K derived: sum of 3 quarters · filed 2016-12-14 | $810.00K derived: sum of 4 quarters · filed 2016-12-14 |
| 2015-07-31 | $398.00K 10-Q · filed 2016-09-14 | $366.00K derived: sum of 2 quarters · filed 2016-09-14 | $343.00K derived: sum of 3 quarters · filed 2016-09-14 | $533.00K derived: sum of 4 quarters · filed 2016-09-14 |
| 2015-04-30 | -$32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | -$55.00K derived: sum of 2 quarters · filed 2016-07-29 | $135.00K derived: sum of 3 quarters · filed 2016-07-29 | -$265.00K 10-K · filed 2016-07-29 |
| 2015-01-31 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | $167.00K derived: sum of 2 quarters · filed 2016-03-16 | -$233.00K 10-Q · filed 2016-03-16 | -$2.03M derived: sum of 4 quarters · filed 2016-03-16 |
| 2014-10-31 | $190.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-15 | -$210.00K 10-Q · filed 2015-12-15 | -$2.01M derived: sum of 3 quarters · filed 2015-12-15 | -$347.00K derived: sum of 4 quarters · filed 2015-12-15 |
| 2014-07-31 | -$400.00K 10-Q · filed 2015-09-11 | -$2.20M derived: sum of 2 quarters · filed 2015-09-11 | -$537.00K derived: sum of 3 quarters · filed 2015-09-11 | -$859.00K derived: sum of 4 quarters · filed 2015-09-11 |
| 2014-04-30 | -$1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | -$137.00K derived: sum of 2 quarters · filed 2015-07-29 | -$459.00K derived: sum of 3 quarters · filed 2015-07-29 | $825.00K 10-K · filed 2015-07-29 |
| 2014-01-31 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | $1.34M derived: sum of 2 quarters · filed 2015-03-17 | $2.62M 10-Q · filed 2015-03-17 | $2.48M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-10-31 | -$322.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $962.00K 10-Q · filed 2014-12-15 | $820.00K derived: sum of 3 quarters · filed 2014-12-15 | $835.00K derived: sum of 4 quarters · filed 2014-12-15 |
| 2013-07-31 | $1.28M 10-Q · filed 2014-09-12 | $1.14M derived: sum of 2 quarters · filed 2014-09-12 | $1.16M derived: sum of 3 quarters · filed 2014-09-12 | |
| 2013-04-30 | -$142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-28 | -$127.00K derived: sum of 2 quarters · filed 2014-07-28 | -$84.00K 10-K · filed 2014-07-28 | |
| 2013-01-31 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-14 | $58.00K 10-Q · filed 2014-03-14 | ||
| 2012-10-31 | $43.00K 10-Q · filed 2013-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |